Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Riccardo TERZI"'
Autor:
Francesco CONDELLO, Matteo MAURINA, Mauro CHIARITO, Matteo STURLA, Riccardo TERZI, Fabio FAZZARI, Jorge SANZ-SANCHEZ, Francesco CANNATA, Gianluigi CONDORELLI, Giulio G. STEFANINI
Publikováno v:
Minerva Cardiology and Angiology. 70
Evidence about the use of direct oral anticoagulants (DOACs) in patients with left ventricular thrombosis (LVT) are emerging. The aim of our study was to provide a comprehensive synthesis of the available evidence concerning the clinical effects of D
Autor:
Mauro Chiarito, Angelo Oliva, Laura Novelli, Riccardo Terzi, Matteo Sturla, Emir Lacevic, Anna Giulia Carnabuci, Damiano Regazzoli, Antonio Mangieri, Alessandro Sticchi, Giuseppe Ferrante, Gabriele Gasparini, Paolo Pagnotta, Antonio Colombo, Roxana Mehran, Lucia Torracca, Gianluigi Condorelli, Bernhard Reimers, Giulio G Stefanini
Publikováno v:
European Heart Journal Supplements. 24
Background Recent evidence has rendered percutaneous coronary intervention (PCI) a valuable alternative to coronary artery bypass grafting (CABG) in patients with left main coronary artery disease (LMCAD). Nevertheless, the optimal management and pat
Autor:
Fabio Fazzari, Francesco Cannata, Mauro Chiarito, Mauro Gitto, Riccardo Terzi, Emanuele Didedda, Costanza Lisi, Gianluigi Condorelli, Giulio Stefanini, Arturo Chiti, Renato Bragato, Marco Francone
Publikováno v:
European Heart Journal Supplements. 24
Introduction Recent published ESC guidelines on non-cardiac surgery suggest the use of imaging stress test in patients with poor functional capacity and high likelihood of coronary artery disease or high clinical risk (class I, level B), while the us
Autor:
Riccardo Terzi, Mauro Chiarito, Angelo Oliva, Alessandra Iaccarino, Laura Novelli, Anna Giuli Carnabuci, Damiano Regazzoli, Antonio Mangieri, Alessandro Sticchi, Giuseppe Ferrante, Matteo Sturla, Gabriele Gasparini, Paolo Pagnotta, Antonio Colombo, Gianluigi Condorelli, Alessandro Barbone, Lucia Torracca, Bernhard Reimers, Roxana Mehran, Giulio G Stefanini
Publikováno v:
European Heart Journal Supplements. 24
Background Recent evidence has rendered percutaneous coronary intervention (PCI) a valuable alternative to coronary artery bypass grafting (CABG) in patients with left main coronary artery disease (LMCAD). Nevertheless, the optimal management and pat
Autor:
Francesco Condello, Michele Cacia, Matteo Sturla, Riccardo Terzi, Jorge Sánz-Sanchez, Bernhard Reimers, Gabriele L. Gasparini, Paolo Pagnotta, Sabato Sorrentino, Carmen Spaccarotella, Ciro Indolfi, Alberto Polimeni
Publikováno v:
Journal of Clinical Medicine; Volume 11; Issue 23; Pages: 7013
Background: Simultaneous ulnar and radial artery compression (SURC) has emerged as a strategy to increase radial artery flow and mitigate radial artery occlusion (RAO) while achieving adequate hemostasis after transradial access (TRA), though its tec
Autor:
Mauro Gitto, Alexios S. Kotinas, Riccardo Terzi, Angelo Oliva, Jorgele Zagoreo, Bernhard Reimers, Giulio G. Stefanini, Marco Mirani, Giuseppe Favacchio, Gianluigi Condorelli, Cristina Panico
Publikováno v:
Journal of cardiovascular pharmacology. 80(1)
Despite large-scale randomized clinical trials (RCTs) highlighting a consistent prognostic benefit of sodium-glucose cotransporter 2 inhibitors (SGLT2is) both in diabetic patients at high cardiovascular risk and in those with heart failure, there is
Autor:
Francesco Condello, Matteo Maurina, Mauro Chiarito, Matteo Sturla, Riccardo Terzi, Fabio Fazzari, Jorge Sanz-Sanchez, Francesco Cannata, Gianluigi Condorelli, Giulio Stefanini
Publikováno v:
European Heart Journal Supplements. 23
Aims Evidence about the use of direct oral anticoagulants (DOACs) in patients with left ventricular thrombosis (LVT) are emerging. The aim of our study was to provide a comprehensive synthesis of the available evidence concerning the clinical effects
Publikováno v:
European Heart Journal Supplements. 23
Aims Current guidelines recommend dual antiplatelet therapy (DAPT) with aspirin and a P2Y12 inhibitor for 6–12 months after percutaneous coronary intervention (PCI). A shorter duration ticagrelor-based DAPT followed by ticagrelor monotherapy can si
Autor:
Mauro Gitto, Alexios Kotinas, Riccardo Terzi, Angelo Oliva, Jorgele Zagoreo, Bernhard Reimers, Giulio G Stefanini, Marco Mirani, Giuseppe Favacchio, Gianluigi Condorelli, Cristina Panico
Publikováno v:
European Heart Journal Supplements. 23
Aims Sodium–glucose cotransporter 2 inhibitors (SGLT2i) have become a first-line cardiovascular medication. However, their potential side effects still limit a widespread use in real-world clinical practice. Further, there is uncertainty about the
Publikováno v:
Journal of Clinical Medicine, Vol 10, Iss 5506, p 5506 (2021)
Journal of Clinical Medicine
Journal of Clinical Medicine
(1) Shorter-duration dual antiplatelet therapy (DAPT) followed by single antiplatelet therapy has been shown to significantly reduce bleeding events while preserving anti-ischemic effects in patients undergoing conventional percutaneous coronary inte